Rheumatoid arthritis: pathogenesis and therapeutic advances

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by the unresolved synovial inflammation for tissues-destructive consequence, which remains one of significant causes of disability and labor loss, affecting about 0.2-1% global population. Although treatments with disease-modifying antirheumatic drugs (DMARDs) are effective to control inflammation and decrease bone destruction, the overall remission rates of RA still stay at a low level. Therefore, uncovering the pathogenesis of RA and expediting clinical transformation are imminently in need. Here, we summarize the immunological basis, inflammatory pathways, genetic and epigenetic alterations, and metabolic disorders in RA, with…

• NN
  National Natural Science Foundation of China

  Awards: 82071790, 82271797, 82341065
• SA
  Science and Technology Commission of Shanghai Municipality

  Award: 23141902300
• NK
  National Key Research and Development Program of China

  Awards: 2023YFC2307302, 2023YFC2307001